Spring til hovednavigation Spring til søgning Spring til hovedindhold

Perioperativ heparin-bridging er sjældent indiceret

Abstract

Meta-analyses of cohort studies and a recent randomized, placebo-controlled study have shown that perioperative bridging of warfarin therapy with therapeutic doses of heparin results in a multi-fold increase in major bleeding but no reduction in the incidence of thromboembolism. It is time to reconsider heparin bridging: When is heparin bridging superfluous? When is prophylactic dosage indicated? And when is it safe to use therapeutic dosing?

Bidragets oversatte titelPerioperative heparin bridging is rarely indicated
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind178
Udgave nummer9
Sider (fra-til)V12150952
ISSN0041-5782
StatusUdgivet - 29 feb. 2016

Emneord

  • Anticoagulants/administration & dosage
  • Hemorrhage/chemically induced
  • Heparin/administration & dosage
  • Heparin, Low-Molecular-Weight/administration & dosage
  • Humans
  • Perioperative Care
  • Thromboembolism/prevention & control
  • Vitamin K/antagonists & inhibitors
  • Warfarin/administration & dosage

Fingeraftryk

Dyk ned i forskningsemnerne om 'Perioperativ heparin-bridging er sjældent indiceret'. Sammen danner de et unikt fingeraftryk.

Citationsformater